Latest Breaking News On - Artms inc - Page 2 : comparemela.com

ARTMS Inc. (ARTMS) is excited to announce Health Canada’s marketing approval of cyclotron produced technetium-99m ( 99mTc) for clinical use. For the Health Canada submission, ARTMS provided technical expertise and the solid targets required for production to a Canadian consortium consisting of BC Cancer, TRIUMF, Lawson Health Research and the Centre for Probe Development and Commercialization. The process was approved by Health Canada on November 26, 2020 and is being deployed immediately. “The Nuclear Medicine community and our patients have seen multiple supply chain challenges with 99mTc and other critical medical isotopes. ARTMS’ QUANTM Irradiation System (QIS TM) provides the ability to produce large volumes of isotopes in a decentralized manner, which will dynamically change how we supply these diagnostic products to clinicians and the patients they serve. The team at ARTMS is proud to have played a key role in the development and eventual approval of cyclotron produ

United kingdomBritish columbiaPaul schafferCharless conroyDoug gentilcoreNuclear medicineHealth canada onArtms incHealth canadaLawson health researchCentre for probe developmentProbe developmentChief technology officerChief executive officerஒன்றுபட்டது கிஂக்டம்பிரிட்டிஷ் கொலம்பியா